Beruflich Dokumente
Kultur Dokumente
DOI 10.1007/s13300-010-0008-2
REVIEW
0008-2
ABSTRACT prevent complications or, in the case of CE, to
intervene rapidly with mannitol or hypertonic
2
The object of this review is to provide saline infusion. Fluid infusion should precede
103 the definitions, frequency, risk factors, insulin administration (0.1 U/kg/h) by 1-2 hours;
pathophysiology, diagnostic considerations, an initial bolus of 10-20 mL/kg 0.9% saline is
and management recommendations for diabetic followed by 0.45% saline calculated to supply
ketoacidosis (DKA) in children and adolescents, maintenance and replace 5%-10% dehydration.
and to convey current knowledge of the causes Potassium (K) must be replaced early and
of permanent disability or mortality from sufficiently. Bicarbonate administration is
complications of DKA or its management, contraindicated. The prevention of DKA at onset
particularly the most common complication, of diabetes requires an informed community and
cerebral edema (CE). DKA frequency at the high index of suspicion; prevention of recurrent
time of diagnosis of pediatric diabetes is DKA, which is almost always due to insulin
10%-70%, varying with the availability of omission, necessitates a committed team effort.
healthcare and the incidence of type 1 diabetes
(T1D) in the community. Recurrent DKA rates Keywords: adolescents; cerebral edema;
are also dependent on medical services and children; complications; diabetic ketoacidosis;
socioeconomic circumstances. Management fluid replacement; hypokalemia; management;
should be in centers with experience and where prevention; recurrent DKA
vital signs, neurologic status, and biochemistry
can be monitored with sufficient frequency to INTRODUCTION
Definition of Diabetic Ketoacidosis
Arlan L. Rosenbloom ()
Adjunct Distinguished Service Professor Emeritus,
Division of Endocrinology, Department of Pediatrics, Diabetic ketoacidosis (DKA) is biochemically
University of Florida College of Medicine, Gainesville, defined as a venous pH <7.3 or serum
Florida, USA. Address correspondence to: Children’s
Medical Services Center, 1701 SW 16th Ave, Gainesville, bicarbonate concentration <15 mmol/L, serum
FL 32608, USA. Email: rosenal@peds.ufl.edu glucose concentration >200 mg/dL (11 mmol/L)
104 Diabetes Ther (2010) 1(2):103-120.
Figure 1. Pathophysiology of diabetic ketoacidosis. Absolute or relative insulin deficiency decreases glucose utilization in
insulin-sensitive tissues and promotes lipolysis. Energy deficiency in these tissues is a stress, stimulating counter-regulatory
hormones (glucagon, catecholamines, growth hormone, cortisol) and proinflammatory cytokines, which also stimulate these
hormones. The counter-regulatory hormones in turn enhance lipolysis and proteolysis, providing a substrate for hepatic
ketogenesis and hepatic and renal gluconeogenesis, all of which results in ketoacidosis, osmotic diuresis, dehydration, and
tissue hypoperfusion, adding lactic acidosis to the metabolic acidosis from accumulated ketones and loss of base in the urine.
Insulin deficiency
Glucagon
Catecholamines
Growth hormone Proinflammatory
Cortisol cytokines
KETOACIDOSIS
Proteolysis & — hepatic gluconeogenesis
Lactic acidosis
Diabetes Ther (2010) 1(2):103-120. 105
deep breathing, and up to 10% with capillary nitrogen; creatinine; osmolality; ketones
refill time greater than 3 seconds and sunken or beta-hydroxybutyrate; hemoglobin and
eyes (Table 1). Calculations of fluid deficit are hematocrit or complete blood count, while
commonly based on 10% dehydration, which keeping in mind that DKA is associated
in most cases is a modest overestimate that does with leukocytosis.
not appear to have clinical significance. 21-22 Osmolality can be measured or calculated
The level of consciousness should be recorded as: 2× (sodium [Na] + K) + glucose in millimoles
using the Glasgow Coma Scale (Table 2). 23 per liter (or glucose in mg/dL/18). The urine
An initial venous blood sample should be should be checked for ketones. If there is any
tested for glucose; electrolytes; pH; urea possibility of delay in obtaining a serum K result,
Diabetes Ther (2010) 1(2):103-120. 107
Flat T-wave
or if there are other factors increasing the risk • Maintenance can be calculated as 1000 mL
for cerebral edema (CE; age under 5 years, low for the first 10 kg body weight + 500 mL for
partial pressure of carbon dioxide [pCO2], high the next 10 kg + 20 mL/kg over 20 kg or
serum urea nitrogen), an intensive care unit, 1500 mL/m2 body surface area.
preferably pediatric, or an equivalent facility • The remainder of replacement after the
is appropriate.2 loading dose, based on 5%-10% dehydration,
and maintenance, can be distributed over
Fluid and Insulin Replacement the subsequent 22-23 hours. While many
guidelines call for calculating replacement
Goals of Treatment with Fluid and Insulin over 48 hours, there is no evidence basis for
• Restore perfusion, which will increase this being safer or more efficacious. Fluids
glucose uptake in the periphery, increase that have recently been administered orally
glomerular filtration, and reverse the at home (if not vomited) and parenteral
progressive acidosis. fluids provided in the emergency room or
• A r r e s t k e t o g e n e s i s w i t h i n s u l i n referring institution need to be incorporated
administration, which reverses proteolysis into the calculation.
and lipolysis while stimulating glucose • Except for severely ill and very young
uptake and processing, thereby normalizing individuals, oral intake should begin before
blood glucose concentration. 24 hours.
• Replace electrolyte losses. • While urinary output should be carefully
• Intervene rapidly when complications, documented, urinary losses should not be
especially CE, occur. added to fluid requirements, except in the
presence of HHS.2,17,20
Fluid Therapy • After initial 0.9% NaCl bolus, rehydration/
• Dehydration can be assumed to be 5%-10% maintenance should be continued with
(50-100 mL/kg). As noted above, the degree 0.45% NaCl. The measured Na can increase
of dehydration is usually overestimated. to the level of the corrected Na during
The severity of extracellular fluid (ECF) rehydration as glycemia declines and then
contraction may be indicated by serum urea decline to normal levels if the corrected
and hematocrit concentrations.11 Serum Na level was elevated.
concentration is not reliable for determining • Continued use of 0.9% saline after the initial
ECF deficit because of the osmotic effect resuscitation may result in hyperchloremic
of hyperglycemia-induced dilutional metabolic acidosis.35,36
hyponatremia33,34 and the low Na content • To prevent unduly rapid decline in plasma
of the elevated lipid fraction of the serum glucose concentration and hypoglycemia,
in DKA. Corrected Na, ie for normal glucose 5% glucose should be added to the IV fluid
levels, can be estimated by adding 1.6 mEq when the plasma glucose falls to 300 mg/dL
to the measured value for each 100 mg/dL (17 mmol/L). An efficient method of
blood glucose above normal.33 providing glucose as needed without
• During the first 1-2 hours, 10-20 mL/kg 0.9% long delays entailed by the changing
sodium chloride (NaCl) should be provided of IV solutions is to have two IV fluid
to restore peripheral perfusion. bags connected, one containing 10%
Diabetes Ther (2010) 1(2):103-120. 109
similar to those in contemporary population- cerebral injury, rather than the type or rate of
based studies. There have been a few case reports fluid administration.2,47,49,65,71
of CE developing before initiation of treatment In the 61 children with CE from a
of DKA and a report from Canada indicated that North American multicenter study, worse
19% of cases of CE were present before treatment outcomes occurred in those with greater
was undertaken.47,49,50,68 neurologic depression at the time of diagnosis
of CE and with higher initial serum urea
Risk Factors nitrogen concentrations. 50,72 Intubation and
Young children, especially <5 years of age, are hyperventilation to a pCO2 of <22 mmHg also was
at increased risk for the development of CE. associated with worse outcome, dictating the need
This may reflect the more rapid deterioration for caution in hyperventilating patients.2,72
in this age group and greater delay in diagnosis
because of nonspecificity of symptoms. The Mechanisms
younger brain might also be more susceptible to CE refers to an increase of cerebral tissue water
metabolic and vascular changes associated with causing an increase of tissue volume. 73 The
DKA. Severity of acidosis, degree of hypocapnia, edema may be vasogenic, due to breakdown of
and elevated serum urea nitrogen, indicators of the blood-brain barrier, such as around a tumor
severity of ketoacidosis and dehydration, have or with trauma; cytotoxic, from poisoning or
been noted to be risk factors.2 Although Na metabolic derangement; or osmotic, as occurs
bicarbonate administration was significantly with hyponatremia. Neither the cause nor the
associated with the development of CE in location of the fluid in the swollen brains of
one population-based case-control study, 50 children with DKA is known. The mechanism
this association may simply reflect the greater is likely to be complex, and it may not be the
severity of ketoacidosis that was not adequately same in all affected individuals, as reflected
controlled for in the case-control design, rather by the time of onset and the brain imaging
than an effect of the bicarbonate.69 findings. The time of onset is distributed in a
CE associated with DKA is rarely seen bimodal fashion, with approximately two-thirds
beyond the pediatric age group (0-21 years)67 of patients developing signs and symptoms in
or in adult patients with HHS, despite rapid the first 6-7 hours and the rest from 10-24 hours
rehydration and restoration of normal after the start of treatment, with the early-onset
glycemia.70 In several studies increased risk of individuals tending to be younger.50,71,72
CE has been associated with a failure of serum Initial brain CT undertaken 2-44 hours after
Na concentration to increase appropriately the diagnosis of CE found 39% with no acute
during treatment for DKA. This may be because abnormalities visible, and this did not differ
those who are in the early, presymptomatic significantly between early and late-onset
stages of CE experience changes in the brain subjects. Twenty-six percent had diffuse edema,
that result in dysregulation of antidiuretic which was also similar between early and late
hormone secretion.50,71 The absence of evidence onset. Three of the eight with diffuse edema
of associations between volume or tonicity of also had hemorrhages, and 17% of the entire
fluids or the rate of change in serum glucose group had only subarachnoid or intraventricular
and risk of CE indicates that this might be hemorrhage. Five subjects had focal brain injury
the result of altered renal Na handling due to in the mesial basal ganglia and thalamus, the
114 Diabetes Ther (2010) 1(2):103-120.
periaqueductal gray matter, and the dorsal or death in one patient, a reasonable proposition
pontine nuclei (22%). These localized injuries considering the alternative of waiting for more
were only in the early-onset patients. They were stringent criteria to be met.
not an artifact of the time that the studies were
performed, and thus, truly reflect what appear to Treatment
be widely varying pathology in the brain leading Improvement has been consistently observed
to the syndrome that is referred to as “idiopathic with administration of IV mannitol in a dosage
CE”. 71 The observation that approximately of 1.0 g/kg over 20 minutes with repeat as
40% of initial brain imaging studies in necessary in 1-2 hours and associated measures
children who have CE are normal emphasizes as soon as CE is suspected, especially before
that CE is a clinical diagnosis requiring the respiratory arrest.2,49,50,65 Intervention includes
initiation of treatment before imaging studies reduction in the rate of fluid administration
are undertaken. and elevation of the head of the bed. Although
early intervention with mannitol treatment has
Monitoring improved outcome, it is difficult to determine
Because treatment modification has not to what degree, because increased recognition
prevented CE and with the strong evidence that of the problem has undoubtedly led to less
early administration of mannitol prevents brain stringent case definition. The application of
damage and death from this complication, Muir criteria developed by Muir et al., when applied
et al. developed a model for early detection.71 to a series of 69 consecutive cases thought to be
Diagnostic criteria were abnormal motor or uncomplicated and experiencing full recovery,
verbal response to pain; decorticate or decerebrate yielded three (4.3%) who would have been
posture; cranial nerve palsy (especially III, appropriately treated with mannitol according
IV, VI); and abnormal neurogenic respiratory to these criteria.71 This is remarkably close to the
pattern (eg, grunting, tachypnea, Cheyne- percentage of DKA patients treated as CE in a
Stokes, apneustic). Major criteria were altered recent report of 18 years experience.76
mentation/fluctuating level of consciousness; Mannitol lowers the hematocrit and blood
sustained heart rate deceleration (decline more viscosity, improving cerebral blood flow (CBF)
than 20 per minute) not attributable to improved and oxygenation, red cell deformability, and
intravascular volume or sleep state; and age- vasoconstriction in areas of the brain with
inappropriate incontinence. Minor criteria intact autoregulation. It may also improve
were vomiting following initial treatment and autoregulation from the effects on CBF and
its cessation, if present at admission; headache oxygenation, and has direct osmotic effects with
(recurrent and more severe than on admission); reduction in extracellular free water. Intensivists
lethargy or not easily aroused from sleep; diastolic frequently express concern about the use of
blood pressure greater than 90 mmHg; and age mannitol because of their experience with the
<5 years. The system allowed 92% sensitivity and risk of rebound edema and renal failure when
96% specificity for the recognition of CE early mannitol is used over an extended period.
enough for intervention, using one diagnostic However, there are no reports of complications
criterion, two major criteria, or one major plus two of mannitol use in this acute situation.
minor criteria. This means that five youngsters Hypertonic saline (HS) has become the standard
will be treated for CE to prevent brain damage for treating acute intracranial hypertension in
Diabetes Ther (2010) 1(2):103-120. 115
head injury and following surgical procedures an example has been provided by the Italian
in the supratentorial region and in these School and Physician Awareness Program
circumstances has been considered at least as directed at 6-14-year-olds, which reduced the
effective as mannitol.75-79 HS for treatment of CE rates of new-onset DKA from 78% to nearly 0%
in DKA was initially described in a 13-year-old over 6 years10 Materials used in this effort are
female patient who developed a severe headache available online.89
20 minutes after the start of treatment and who In the 1970s, a comprehensive approach
had CT evidence of diffuse CE with transtentorial involving outreach clinics, frequent routine and
herniation. She continued to deteriorate despite emergency telephone contact, and a camping
mannitol treatment and was given 5 mL/kg of program supported by state funding for children
3% saline rapidly; she awoke with recovered with special healthcare needs dramatically
neurologic function within 5 minutes.80 The use reduced recurrent DKA episodes. Private
of 5-10 mL/kg 3% saline in patients who have not patients in the program had a reduction in
responded adequately to mannitol infusion of a hospital admission days from preintervention of
dose of 1 g/kg appears justified. 2.8/patient/year to 0.3 and in the second
Intubation should be reserved for those year to 0. The children sponsored by the state
with respiratory compromise, but should not program had a reduction from 4.9/patient/year
be undertaken simply because of the diagnosis to 1.8 and in the second year to 0.9.15
of CE. Aggressive hyperventilation was a Patients with compliance problems account
significant risk factor for poor outcome in the for a disproportionate number of recurrent
study of Marcin et al.,72 similar to detrimental DKA episodes. In the UK surveillance study,
effects reported in head trauma and high- 4.8% of patients accounted for 22.5% of all
altitude exposure.81,82 episodes68 and as noted above, 20% of patients
in Colorado accounted for 80% of recurrent DKA
Intracerebral Complications other than CE episodes.14 The principal immediate reason for
the recurrent DKA in children and adolescents
Approximately 10% of all instances of is insulin omission, reflected in low or absent
neurologic collapse during ketoacidosis can levels of free insulin.27 The necessity for assuring
be attributed to intracerebral complications, administration of insulin by responsible adults
with or without associated edema, but by is critical.
definition not idiopathic CE.2 The causes include
subarachnoid hemorrhage, 49 basilar artery CONCLUSION
thrombosis,49 cerebral venous thrombosis,83,85
meningoencephalitis, 86 and disseminated DKA is the result of absolute or relative
intravascular coagulation.87,88 deficiency of insulin in combination with
exuberant secretion of counter-regulatory
PREVENTION OF DKA hormones (glucagon, catecholamines, cortisol,
growth hormone) resulting in blockade of
Prevention of DKA at onset is most dramatically glucose utilization in insulin-sensitive tissues
demonstrated when early diagnosis is made (liver, fat, muscle) and a cascade of derangement
through genetic and immunologic screening of progressing to ketoacidosis and dehydration.
high-risk children.7,15 For the general population, Much new-onset DKA can be prevented by
116 Diabetes Ther (2010) 1(2):103-120.
increased awareness of early signs and symptoms with 0.45% saline, and early and adequate
of diabetes and, in principle, almost all K replacement.
recurrent DKA is preventable by informed sick • Insulin should not be given as a bolus, but
day management, recognition of psychosocial infused after the initial fluid resuscitation in
problems leading to insulin omission, and a dose of 0.1 U/kg of body weight/hour.
careful monitoring of insulin pump function. • Bicarbonate infusion is contraindicated in
Management of DKA should occur in centers pediatric DKA.
with treatment experience and monitoring • CE is the most common serious complication,
capability. Fluid replacement begins with 0.9% requiring careful neurologic and vital sign
saline to restore circulation and subsequent monitoring and early intervention with
0.45% saline for maintenance and replacement mannitol or hypertonic saline infusion.
of 5%-10% dehydration, according to severity
indicators. Whether levels of serum K are normal ACKNOWLEDGMENTS
or elevated, there will be a total K deficit that must
be dealt with early and sufficiently. Bicarbonate The author has no conflicts of interest to declare.
administration is neither necessary nor safe. A.L.R. is the guarantor for this article, and takes
Mannitol or hypertonic saline should be at the responsibility for the integrity of the work as
bedside, for rapid intervention as indicated for a whole.
CE, the most common serious complication of
DKA. Other complications include hypokalemia, Open Access. This article is distributed
hypophosphatemia, hypoglycemia, intracerebral under the terms of the Creative Commons
complications other than CE, peripheral Attribution Noncommercial License which
venous thrombosis, mucormycosis, aspiration permits any noncommercial use, distribution,
pneumonia, rhabdomyolysis, acute pancreatitis, and reproduction in any medium, provided the
and acute renal failure. Among questions that original author(s) and source are credited.
need to be addressed regarding DKA in children
and adolescents are whether feasible and cost- REFERENCES
effective methods can reduce the frequency of
new-onset and recurrent DKA, what characterizes 1. American Diabetes Association. Position statement:
optimal fluid replacement therapy, how effective hyperglycemic crises in patients with diabetes
mellitus. Diabetes Care. 2001;24:S83-S90.
proposed monitoring and intervention criteria
are in the reduction of CE morbidity and 2. Wolfsdorf J, Craig ME, Daneman D, et al. Diabetic
ketoacidosis in children and adolescents with
mortality, and whether hypertonic saline is as or
diabetes. Pediatr Diabetes. 2009;10(Suppl. 12):
more effective than mannitol in the treatment 118-133.
of CE.
3. Burge MR, Hardy KJ, Schade DS. Short-term fasting
is a mechanism for the development of euglycemic
Key points ketoacidosis during periods of insulin deficiency. J
Clin Endocrinol Metab. 1993;76:1192-1198.
• Treatment of DKA requires first and foremost 4. Pinkey JH, Bingley PJ, Sawtell PA, Dunger DB,
fluid resuscitation with 0.9% saline, followed Gale EA. Presentation and progress of childhood
diabetes mellitus: a prospective population-based
by replacement for 5%-10% dehydration, study. The Bart’s-Oxford Study Group. Diabetologia.
depending on severity, and maintenance 1994;37:70-74.
Diabetes Ther (2010) 1(2):103-120. 117
5. Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. 17. Rosenbloom AL. Hyperglycemic hyperosmolar
Hyperglycemic crises in adult patients with state: an emerging pediatric problem. J Pediatr.
diabetes. Diabetes Care. 2009;32:1335-1343. 2010;156:180-184.
6. Foster DW, McGarry JD. The metabolic 18. McDonnell CM, Pedreira CC, Vadamalayan B,
derangements and treatment of diabetic Cameron FJ, Werther GA. Diabetic ketoacidosis,
ketoacidosis. N Engl J Med. 1983;309:159-169. hyperosmolarity and hypernatremia: are high-
carbohydrate drinks worsening initial presentation?
7. Lévy-Marchal C, Patterson CC, Green A, on behalf Pediatr Diabetes. 2005;6:90-94.
of the EURODIAB ACE study group. Geographical
variation of presentation at diagnosis of type 1 19. Morales A, Rosenbloom AL. Death caused by
diabetes in children: the EURODIAB Study. hyperglycemic hyperosmolar state at the onset of
Diabetologia. 2001;44(Suppl. 3):B75-B80. type 2 diabetes. J Pediatr. 2002;144:270-273.
8. Bui TP, Werther GA, Cameron EJ. Trends in diabetic 20. Canarie MF, Bogue CW, Banasiak KJ, Weinzimer SA,
ketoacidosis in childhood and adolescence: a 15-yr Tamborlane WV. Decompensated hyperglycemic
experience. Pediatr Diabetes. 2002;3:82-88. hyperosmolarity without significant ketoacidosis
in the adolescent and young adult population. J
9. Jackson W, Hoffman PL, Robinson EM, Elliot RB, Pediatr Endocrinol Metab. 2007;20:1115-1124.
Pilcher CC, Cutfield WS. The changing presentation
of children with newly diagnosed type 1 diabetes 21. Koves IH, Neutze J, Donath S, et al. The accuracy of
mellitus. Pediatr Diabetes. 2001;2:154-159. clinical assessment of dehydration during diabetic
ketoacidosis in childhood. Diabetes Care. 2004;
10. Vanelli M, Chiari G, Ghizzoni L, Costi G,
27:2485-2487.
Giacalone T, Chiarelli F. Effectiveness of a
prevention program for diabetic ketoacidosis in
22. Fagan MJ, Avner J, Khine H. Initial fluid
children. An 8-year study in schools and private
resuscitation for patients with diabetic ketoacidosis:
practices. Diabetes Care. 1999;22:7-9.
how dry are they? Clin Pediatr. 2008;47:851-855.
11. Mallare JT, Cordice CC, Ryan BA, Carey DE,
23. Teasdale G, Jennett B. Assessment of coma and
Kreitzer PM, Frank GR. Identifying risk factors
impaired consciousness. A practical scale. Lancet.
for the development of diabetic ketoacidosis in
1974;2:81-84.
new onset type 1 diabetes mellitus. Clin Pediatr.
2003;42:591-597.
24. Malone JI, Brodsky SJ. The value of
electrocardiogram monitoring in diabetic
12. Maniatis AK, Goehrig SH, Gao D, Rewers A,
Walravens P, Klingensmith G. Increased incidence ketoacidosis. Diabetes Care. 1980;3:543-547.
and severity of diabetic ketoacidosis among
uninsured children with newly diagnosed type 1 25. Soler NG, Bennett MA, Fitzgerald MG, Malins JM.
diabetes mellitus. Pediatr Diabetes. 2005;6:79-83. Electrocardiogram as a guide to potassium
replacement in diabetic ketoacidosis. Diabetes.
13. Neu A, Willasch A, Ehehalt S, Hub R, Ranke MB, on 1974;23:610-615.
behalf of the DIARY group Baden-Wuerttemberg.
Ketoacidosis at onset of type 1 diabetes mellitus 26. Schatz DA, Rosenbloom AL. Diabetic ketoacidosis:
in children – frequency and clinical presentation. management tactics in young patients. J Crit
Pediatr Diabetes. 2003;4:77-80. Illness. 1988;3:29-41.
14. Roche EF, Menon A, Gill D, Hoey H. Clinical 27. Malone JI, Root AW. Plasma free insulin
presentation of type 1 diabetes. Pediatr Diabetes. concentrations: keystone to effective management
2005;6:75-78. of diabetes mellitus in children. J Pediatr.
1981;99:862-867.
15. Giordano B, Rosenbloom AL, Heller DR, Weber FT,
Gonzales R, Grgic A. Regional services for children 28. Rosenbloom AL, Hanas R. Diabetic ketoacidosis
and youth with diabetes. Pediatrics. 1977;60: (DKA): treatment guidelines. Clin Pediatr.
492-498. 1996;35:261-266.
16. Golden MP, Herrold AJ, Orr DP. An approach to 29. Bonadio WA, Gutzeit MF, Losek JD, Smith DS.
prevention of recurrent diabetic ketoacidosis in the Outpatient management of diabetic ketoacidosis.
pediatric population. J Pediatr. 1985;107:195-200. Am J Dis Child. 1988;142:448-450.
118 Diabetes Ther (2010) 1(2):103-120.
30. Linares MY, Schunk JE, Lindsay R. Laboratory patients with diabetic ketoacidosis. Am J Med.
presentation in diabetic ketoacidosis and duration 2004;117:291–296.
of therapy. Pediatr Emerg Care. 1996;12:147-151.
43. Umpierrez GE, Cuervo R, Karabell A, Latif K,
31. Chase HP, Garg SK, Jelley DH. Diabetic ketoacidosis Freire AX, Kitabchi AE. Treatment of diabetic
in children and the role of outpatient management. ketoacidosis with subcutaneous insulin aspart.
Pediatr Rev. 1990;11:297-304. Diabetes Care. 2004;27:1873-1878.
32. Rosenbloom AL, Schatz DA. Diabetic ketoacidosis 44. Della Manna T, Steinmetz L, Campos PR, et al.
in childhood. Pediatr Ann. 1994;23:284-288. subcutaneous use of a fast-acting insulin analog:
an alternative treatment for pediatric patients
33. Katz MA. Hyperglycemia-induced hyponatremia – with diabetic ketoacidosis. Diabetes Care.
calculation of expected serum sodium depression. 2005;28:1856-1861.
N Engl J Med. 1973;289:843-844.
45. Levitsky L, Ekwo E, Goselink CA, Solomon EL,
34. Hillier TA, Abbott RD, Barrett EJ. Hyponatremia: Aceto T. Death from diabetes (DM) in hospitalized
evaluating the correction factor for hyperglycemia. children (1970-1998). Pediatr Res. 1991;29: Abstract
Am J Med. 1999;106:399-403. A195.
35. Adrogue HJ, Eknoyan G, Suki WK. Diabetic 46. Curtis JR, To T, Muirhead S, Cummings E,
ketoacidosis: role of the kidney in the acid- Daneman D. Recent trends in hospitalization for
base homeostasis re-evaluated. Kidney Int. diabetic ketoacidosis in Ontario children. Diabetes
1984;25:591-598. Care. 2002;25:1591-1596.
36. Oh MS, Carroll HJ, Uribarri J. Mechanism of 47. Lawrence SE, Cummings EA, Gaboury I,
Daneman D. Population-based study of incidence
normochloremic and hyperchloremic acidosis in
and risk factors for cerebral edema in pediatric
diabetic ketoacidosis. Nephron. 1990;54:1-6.
diabetic ketoacidosis. J Pediatr. 2005;146:688-692.
37. Poirier MP, Greer D, Satin-Smith M. A prosp-
48. Edge JA, Ford-Adams ME, Dunger DB. Causes of
ective study of the “two bag system” in diabetic
death in children with insulin-dependent diabetes
ketoacidosis management. Clin Pediatr. 2004;
1990-96. Arch Dis Child. 1999;81:318-323.
43:809-813.
49. Rosenbloom AL. Intracerebral crises during
38. Rosenbloom AL, Ongley JP. Serum calcium
treatment of diabetic ketoacidosis. Diabetes Care.
phosphorus and magnesium decrement during
1990;13:22-33.
oral glucose tolerance testing: alteration in pre
clinical and overt diabetes mellitus in childhood. 50. Glaser N, Barnett P, McCaslin I, et al. Risk factors
In: Catin M, Selig M, eds. Magnesium in Health for cerebral edema in children with diabetic
and Disease. New York: Spectrum Publishers Inc.; ketoacidosis. N Engl J Med. 2001;344:264-269.
1980: 297-304.
51. Zipf WB, Bacon GE, Spencer ML, Kelch RP,
39. Edge J, Jakes R, Roy Y, et al. The UK case- Hopwood NJ, Hawker CD. Hypocalcemia, hypo-
control study of cerebral oedema complicating magnesemia, and transient hypoparathyroidism
diabetic ketoacidosis in children. Diabetologia. during therapy with potassium phosphate in
2006;49:2002-2009. diabetic ketoacidosis. Diabetes Care. 1979;2:
265-268.
40. Fisher J, Shahshahani M, Kitabch A. Diabetic
ketoacidosis: low dose insulin therapy by various 52. Winter RJ, Harris CJ, Phillips LS, Green OC.
routes. N Engl J Med. 1977;297:238-243. Diabetic ketoacidosis. Induction of hypocalcemia
and hypomagnesemia by phosphate therapy. Am J
41. Sacks HS, Shahshahani M, Kitabchi, AE, Fisher JN, Med. 1979;67:897-900.
Young RT. Similar responsiveness of diabetic
ketoacidosis to low-dose insulin by intramuscular 53. Gutierrez JA, Bagatell R, Samson MP, Theodorou AA,
injection and albumin-free infusion. Ann Intern Berg RA. Femoral central venous catheter-associated
Med. 1979;90:36-42. deep venous thrombosis in children with diabetic
ketoacidosis. Crit Care Med. 2003;31:80-83.
42. Umpierrez GE, Latif K, Stoever J, et al. Efficacy of
subcutaneous insulin lispro versus continuous 54. Worly JM, Fortenberry JD, Hansen I, Chambliss CR,
IV regular insulin for the treatment of Stockwell J. Deep venous thrombosis in children
Diabetes Ther (2010) 1(2):103-120. 119
with diabetic ketoacidosis and femoral central for diabetic ketoacidosis with fluids of different
venous catheters. Pediatrics. 2004;113:57-60. tonicity. Diabetes Res Clin Practice. 2002;57:87-92.
55. Zeitler P, Thiede A, Muller HL. Prospective 68. Edge JA, Hawkins MM, Winter DL, Dunger DB. The
study on plasma clotting parameters in diabetic risk and outcome of cerebral oedema developing
children – no evidence for specific changes in during diabetic ketoacidosis. Arch Dis Child.
coagulation system. Exp Clin Endorinol Diabetes. 2001;85:16-22.
2001;109:146-152.
69. Dunger DB, Edge JA. Predicting cerebral edema
56. Carl CF, Hoffman WH, Passmore GG, et al. Diabetic during diabetic ketoacidosis. N Engl J Med.
ketoacidosis promotes a prothrombotic state. Endo 2001;344:302-303.
Res. 2003;29:73-82.
70. Carroll P, Matz R. Uncontrolled diabetes mellitus in
57. De Stefano V, Rossi E, Paciaroni K, Leone G. adults: experience in treating diabetic ketoacidosis
Screening for inherited thrombophilia: indications and hyperosmolar nonketotic coma with low dose
and therapeutic implications. Haematologica. insulin and a uniform treatment regimen. Diabetes
2002;87:1095-1108. Care. 1983;6:579-585.
58. Haller MJ, Valladares A, Rosenbloom AL. Arterial 71. Muir AB, Quisling RG, Yang MCK, Rosenbloom AL.
thrombosis resulting in amputation in a child with Cerebral edema in childhood diabetic ketoacidosis.
poorly controlled type 1 diabetes and heterozygous Natural history, radiographic findings, and early
factor V Leiden mutation. Pediatr Diabetes. identification. Diabetes Care. 2004;27:1541-1546.
2006;7:229-231.
72. Marcin JP, Glaser N, Barnett P, et al. Factors
59. Haddad NG, Croffie JM, Rugster EA. Pancreatic associated with adverse outcomes in children with
enzyme elevations in children with diabetic diabetic ketoacidosis-related cerebral edema. J
ketoacidosis. J Pediatr. 2004;145:122-124. Pediatr. 2002;141:793-797.
60. Casteels, K, Beckers D, Wouters C, Van Geet C. 73. Pappius HM. Fundamental aspects of brain edema.
Rhabdomyolysis in diabetic ketoacidosis. Pediatr In: Vinkin PJ, Bruyn GW, eds. Handbook of Clinical
Diabetes. 2003;4:29-31. Neurology. Volume 16. Part 1. Tumors of the Brain
and Skull. Amsterdam: North Holland Publishing
61. Buckingham BA, Roe TF, Yoon J-W. Rhabdomyolysis Co.; 1974:167-185.
in diabetic ketoacidosis. Am J Dis Child.
1981;135:352-354. 74. Fiordalisi I, Novotny WE, Holbert D, Finberg L,
Harris, GD. Critical Care Management Group.
62. Moye J, Rosenbloom AL, Silverstein J. Clinical An 18-yr prospective study of pediatric diabetic
predictors of mucormycosis in type 1 diabetes ketoacidosis: an approach to minimizing the risk
in children. J Ped Endocrinol Metab. 2002; of brain herniation during treatment. Pediatr
15:1001-1004. Diabetes. 2007;8:142-149.
63. Young E, Bradley RF. Cerebral edema with 75. Freshman SP, Battistella FD, Matteucci M,
irreversible coma in severe diabetic ketoacidosis. N Wisner DH. Hypertonic saline (7.5%) versus
Engl J Med. 1967;276:665-669. mannitol: a comparison for treatment of acute
head injuries. J Trauma. 1993;35:344-348.
64. Rosenbloom AL, Riley WJ, Weber FT, Malone JI,
Donnelly WH. Cerebral edema complicating 76. Berger S, Schurer L, Hartl R, Messmer K,
diabetic ketoacidosis in childhood. J Pediatr. Baethmann A. Reduction of post-traumatic
1980;96;357-361. intracranial hypertension by hypertonic/
hyperoncotic saline/dextran and hypertonic
65. Bello FA, Sotos JF. Cerebral oedema in diabetic mannitol. Neurosurgery. 1995:37:98-107.
ketoacidosis in children. Lancet. 1990;336;64.
77. Gemma M, Cozzi S, Tommasino C, et al. 7.5%
66. Brown TB. Cerebral oedema in childhood diabetic hypertonic saline versus 20% mannitol during
ketoacidosis: is treatment a factor? Emerg Med J. elective neurosurgical supratentorial procedures. J
2004;21:141-144. Neurosurg Anesthesiol. 1997:9:329-334.
67. Azzopardi J, Gatt A, Zammit A, Albert G. Lack 78. Worthley LI, Cooper DJ, Jones N. Treatment
of evidence of cerebral edema in adults treated of resistant intracranial hypertension with
120 Diabetes Ther (2010) 1(2):103-120.
hypertonic saline. Report of two cases. J Neurosurg. during diabetic ketoacidosis. Arch Dis Child.
1988:68:478-481. 2002;86:204-206.
79. Qureshi AL, Suarez JI. Use of hypertonic saline 85. Rosenbloom AL. Fatal cerebral infarctions in
solutions in treatment of cerebral edema and diabetic ketoacidosis in a child with previously
intracranial hypertension. Crit Care Med. unknown heterozygosity for factor V Leiden
2000:28:3301-3313. deficiency. J Pediatr. 2004;145:561-562.
80. Curtis JR, Bohn D, Daneman D. Use of hypertonic 86. Yoon J-W, Austin M, Onodera T, Notkins AL.
saline in the treatment of cerebral edema in Virus-induced diabetes mellitus. N Engl J Med.
diabetic ketoacidosis (DKA). Pediatr Diabetes. 1979;300:1173-1179.
2001;2:191-194.
87. Cooper RM. Turner RA, Hutaff L, Prichard R.
81. Shapiro HM, Drummond JC. Neurosurgical Diabetic keto-acidosis complicated by disseminated
anesthesia. In: Miller RD (ed). Anesthesia. 3rd
intravascular coagulation. South Med J.
edition. New York: Churchill Livingstone;
1973;66:653-657.
1990:1913-1914.
88. Bonfanti R, Bognetti E, Meschi F, Medaglini S,
82. Muizelaar JP, Marmarou A, Ward JD, et al. Adverse
D’Angelo A, Chiumello G. Disseminated
effects of prolonged hyperventilation in patients
with severe head injury: a randomized clinical trial. intravascular coagulation and severe peripheral
J Neurosurg. 1991;75:731-739. neuropathy complicating ketoacidosis in a
newly diagnosed diabetic child. Acta Diabetol.
83. Roberts MD, Slover RH, Chase HP. Diabetic 1994;31:173-174.
ketoacidosis with intracerebral complications.
Pediatr Diabetes. 2001;2:109-114. 89. World Diabetes Day. DKA Awareness. Available at:
http://www.worlddiabetesday.org/DKA. Accessed
84. Keane S, Gallagher A, Aykroyd S, McShane December 1, 2010.
MA, Edge JA. Cerebral venous thrombosis